The aim of this study was to examine the effect of Ramadan fasting on ambulatory blood pressure in treated subjects with grade 2-3 hypertension using combination drug therapy. Twenty-four hours ambulatory blood pressure monitoring was performed during and 1 month after Ramadan. No statistically significant difference was found between 24 h mean blood pressures in the two monitoring periods, except for a small rise before dawn while having a morning meal.
Every year, over one billion Moslems fast during the month of Ramadan because of the fundamental requirement of the Islam. This ritual causes marked changes in sleep and feeding patterns. People wake up before dawn to have a meal to prepare themselves for fasting and then go back to bed for a nap. They abstain from drinking and smoking from dawn till dusk and have a large meal after sunset. These life style changes affect drug intake time and dosing, and may cause deleterious effects in patients with hypertension. 1 Alterations in the pharmacokinetics and pharmacodynamics of the drugs may be additional problems. 2 It is claimed that people with mild hypertension can safely undertake Ramadan fasting with oncedaily preparations.
3 Grade 2-3 hypertension is associated with moderate to very high added cardiovascular risk, and combination therapy is recommended for effective blood pressure (BP) control in these patients. 4 The influence of the Ramadan fasting on BP in patients with combination therapy has not been addressed specifically. The aim of this study was to examine the effect of Ramadan fasting on ambulatory BP in these patients.
The study group consisted of 45 treated patients with grade 2-3 hypertension (30 female, 15 male; mean age 58712 years) who declared to do the Ramadan fasting and accepted to be participants of the study. Ten patients with grade 2 hypertension (six female, four male; mean age 58710 years) using monotherapy with once-daily preparations served as the control group. Exclusion criteria were uncontrolled, malignant or secondary hypertension, diabetes mellitus, chronic renal or hepatic disease, cerebrovascular events, left ventricular dysfunction, coronary artery disease, atrial flutter and atrial fibrillation.
Neither the type nor the dosage of the antihypertensive drugs was changed between the Ramadan and the following month. Patients in the study group were using angiotensin-converting enzyme inhibitors (22 patients), AT2 receptor blockers (21 patients), calcium channel blockers (28 patients), diuretics (29 patients), b-blockers (11 patients) and a-blockers (8 patients). Mean number of antihypertensive drugs was 2.770.8. In Ramadan, patients took their drugs in 2 doses, first one at just before the beginning and the second one at the break of fasting. The patients who use one drug as a fixed-dose combination treatment (n ¼ 7) and monotherapy group took their drugs before sunrise. In the following month, drug intake times were the same as usual.
All patients had a 24 h ambulatory BP monitoring (SpaceLabs, model 90207) twice, first in the month of Ramadan and the second in the following month. Monitoring periods started between 1000 and 1200 hours.
The data were analysed using the Statistical Package for Social Sciences for Windows, version 13.0. Overall, daytime, night time and hour-by-hour analysis of the two monitoring periods was compared with paired samples t-test. A P-value o0.05 was accepted as statistically significant.
Sleeping periods and mealtimes changed significantly during Ramadan. All patients woke up before sunrise to have a meal before fasting (0400-0500 hours) and most of them went to bed for a nap between 0600 and 0800 hours. Average body weight did not change significantly between Ramadan and the following month (77.6712.9 vs 77.8712.8 kg, respectively). Average 24 h ambulatory BP in the whole group was 127715/7578 mm Hg in Ramadan vs 128717/76711 mm Hg in the following month (not significant). Overall, daytime and night time mean values of systolic and diastolic BP were not different between the two monitoring periods in both groups (overall BP in Ramadan and following month: 128715/7579 vs 129718/76711 mm Hg in combination therapy and 12178/7577 vs 12479/ 7778 mm Hg in monotherapy group). Systolic and diastolic BP values at 0400-0500 hours (during morning meal) were significantly higher, but still within normal limits, in Ramadan (126720/74712 vs 118717/68712 mm Hg; P ¼ 0.004). However, mean BP during the following nap hours was significantly lower than in the following month (117716/66711 vs 127720/75711 mm Hg; Po0.001) (Figure 1) .
Most of the Moslem patients with chronic illnesses, like hypertension, insist on fasting even though they are permitted not to by Islamic rules and visit their physicians for medical advice. Especially grade 2-3 hypertension patients using combination therapy cause their physicians concern. Results of this study show that in patients with controlled grade 2-3 hypertension, 24 h, daytime and night time BP do not change during Ramadan fasting. Although statistically significant changes were observed in hour-by-hour analysis, these changes were within normal limits and related to the life style changes like waking up early in the morning. All the patients were using once-daily drugs and most of the patients in combination treatment group took their drugs in two separate times (before and at the break of fasting) and that regimen seems to be enough for controlling blood pressure during Ramadan. These findings suggest that Ramadan fasting is safe even for patients with moderate-severe hypertension, unless they have uncontrolled hypertension.
As far as we know, there are only two studies about the BP control during Ramadan. 3, 5 Both of them performed ambulatory BP monitoring before and during Ramadan fasting, and did not find a significant difference among the mean BP of 24 h, diurnal and nocturnal periods. They did not specifically address the question of Ramadan fasting in moderate-severe hypertension needing combination therapy. They compared BP values before and during Ramadan, when a significant weight loss occurs with fasting. The effect of weight loss might have been an important factor for the neutral effect of the Ramadan fasting on BP. In our study, ambulatory BP monitoring was performed during and after Ramadan. As our patients group maintained their weight during the study, the observed effects can only be attributed to life style changes and effective control of BP with long-acting antihypertensives. Other factors that may explain the neutral effect of Ramadan can be summarized as follows: During Ramadan, people tend to decrease their physical activity in the fasting hours and increase daytime sleepiness. 6 The energy restriction has substantial impact on the autonomic nervous system, leading to an increase in vagal and a decrease in sympathetic tone. 7 Other haemodynamic adaptations appear to include augmented cardiac baroreflex sensitivity, loss of plasma volume and reduced venous return. [8] [9] [10] The present study has some limitations: (1) hypertensive patients with associated clinical conditions like diabetes mellitus, chronic renal failure and so on were excluded from the study due to ethical concerns. (2) A certain period of time (for example, last week of the Ramadan month) was not set for Holter monitoring and the physiological changes may not be similar in the first and the last days of the Ramadan. (3) As Ramadan fell in winter in this study, fasting duration changed between 12 and 13 h. However, if Ramadan falls in summer time, the required period for fasting can last up to 18 h and the interval between the two drugs may decrease to 6 h. The pharmacokinetic and pharmacodynamic effects of a long-lasting fasting are unknown. What is known about the topic:
K Ramadan fasting can safely be undertaken in patients with mild to moderate hypertension treated with monotherapy. K Data was limited when to take antihypertensive drugs during Ramadan fasting, especially when the patients are on combination treatment.
What this study adds: K Ramadan fasting seems to be safe also in patients with moderate to severe hypertension treated with combination therapy. K Taking antihypertensives two times (for example, before fasting in the morning and just after the breaking fast in the evening) seems to be a suitable regimen for blood pressure control.
